1. Home
  2. AVXL vs GRC Comparison

AVXL vs GRC Comparison

Compare AVXL & GRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • GRC
  • Stock Information
  • Founded
  • AVXL 2004
  • GRC 1933
  • Country
  • AVXL United States
  • GRC United States
  • Employees
  • AVXL N/A
  • GRC N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • GRC Fluid Controls
  • Sector
  • AVXL Health Care
  • GRC Industrials
  • Exchange
  • AVXL Nasdaq
  • GRC Nasdaq
  • Market Cap
  • AVXL 956.7M
  • GRC 1.0B
  • IPO Year
  • AVXL N/A
  • GRC N/A
  • Fundamental
  • Price
  • AVXL $9.95
  • GRC $41.21
  • Analyst Decision
  • AVXL Strong Buy
  • GRC
  • Analyst Count
  • AVXL 2
  • GRC 0
  • Target Price
  • AVXL $44.00
  • GRC N/A
  • AVG Volume (30 Days)
  • AVXL 1.2M
  • GRC 70.8K
  • Earning Date
  • AVXL 08-12-2025
  • GRC 07-25-2025
  • Dividend Yield
  • AVXL N/A
  • GRC 1.79%
  • EPS Growth
  • AVXL N/A
  • GRC 51.35
  • EPS
  • AVXL N/A
  • GRC 1.97
  • Revenue
  • AVXL N/A
  • GRC $673,880,000.00
  • Revenue This Year
  • AVXL N/A
  • GRC $4.50
  • Revenue Next Year
  • AVXL N/A
  • GRC $4.50
  • P/E Ratio
  • AVXL N/A
  • GRC $20.90
  • Revenue Growth
  • AVXL N/A
  • GRC 2.60
  • 52 Week Low
  • AVXL $4.93
  • GRC $30.87
  • 52 Week High
  • AVXL $14.44
  • GRC $43.79
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 39.87
  • GRC 54.55
  • Support Level
  • AVXL $9.90
  • GRC $40.74
  • Resistance Level
  • AVXL $11.70
  • GRC $43.62
  • Average True Range (ATR)
  • AVXL 0.70
  • GRC 1.15
  • MACD
  • AVXL -0.23
  • GRC -0.05
  • Stochastic Oscillator
  • AVXL 1.62
  • GRC 39.32

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About GRC Gorman-Rupp Company (The)

Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.

Share on Social Networks: